CTRI/2017/09/009942
Not yet recruiting
未知
Clinical Evaluation of Combined Effectiveness of Vatari Guggulu and Pippalyadi Taila Matra Basti in Management of Gridhrasi (Sciatica)
ri Dharmasthala Manjunatheshwara College of Ayurveda and HospitalHassan0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: null- Gridhrasi (Sciatica)
- Sponsor
- ri Dharmasthala Manjunatheshwara College of Ayurveda and HospitalHassan
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •(a) DIAGNOSTIC CRITERIA
- •Patients with features of Gridhrasi (sciatica) like
- •1\. Ruk on SphikPoorva, Kati, Prishta, Uru, Janu, Jangha and Pada Paryanta (Pain radiates from low back to the leg/s)
- •2\. Toda (Pricking sensation)
- •3\. Stambha (Stiffness)
- •4\. Spandana (Fasciculation)
- •5\. Positive Straight Leg Raising test
- •6\. Positive Breggardâ??s sign
- •7\. Laseagueâ??s sign
- •8\. Bowstring sign
Exclusion Criteria
- •1\. Neoplastic and infective conditions of the spine
- •2\. Uncontrolled Diabetes mellitus, Uncontrolled Hypertension, Neurological complications
- •4\. Fractures of pelvis and femur
- •5\. Pregnancy
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
To compare the effect of Varmam therapy and vasavennai oil for shoulder joint degeneratioHealth Condition 1: M00-M99- Diseases of the musculoskeletal system and connective tissueCTRI/2019/08/020731Dr Vrindha KV
Recruiting
Not Applicable
Pulp protecting agents for primary teethCTRI/2024/02/063229Siddhi Kamble
Recruiting
Phase 2
A clinical study of Vranari Guggulu and Vrana lepa in the management of Diabetic Foot UlcerHealth Condition 1: null- Diabetic Foot UlcerCTRI/2015/02/005586DrNRS GovtAyurvedic College100
Recruiting
Phase 4
Effect of herbal medicine Vranari Guggulu and Vrana lepa for Diabetic Foot woundCTRI/2015/02/005587Dr Chadalawada Venkata Siva Koteswara Rao100
Recruiting
Phase 2
Venlafaxine and Bupropione in diabetic patients with depressioType 2 diabetes mellitus.Type 2 diabetes mellitusIRCT20150630022991N12Babol University of Medical Sciences60